Skip to content

Twitter Accounts Hyped Company Seeking Covid Vaccine Trials

  • Network of bot-like accounts promoted Ocugen, researchers say
  • Suspicious activity coincided with request to test vaccine
Updated on

A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News. 

The tweets promoted stock for Ocugen Inc., which is based in Malvern, Pennsylvania, at rates well above market value, according to research by Alethea Group, a startup that tracks disinformation. The company’s share price nearly doubled in a little more than a week.